Back
Calamos Strategic Total Return Fund Vs. Gilead Sciences Industry Stock Comparison
Buy
73
CSQ
Calamos Strategic Total Return Fund
Last Price:
17.27
Seasonality Move:
0.49%
Buy
54
GILD
Gilead Sciences
Last Price:
83.61
Seasonality Move:
3.02%
Buy
73
Calamos Strategic Total Return Fund (CSQ)
is a Buy
Is Calamos Strategic Total Return Fund a Buy, Sell or Hold?
- The current Calamos Strategic Total Return Fund [CSQ] share price is $17.27. The Score for CSQ is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- CSQ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $83.61. The Score for GILD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CSQ Stock Price Chart
What is Calamos Strategic Total Return Fund's stock price today?
-
The Calamos Strategic Total Return Fund share price today is $17.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSQ is experiencing slight buying pressure.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $83.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing slight selling pressure.
CSQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 61.48 | Buy |
| Chaikin Money Flow: | 58929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.64 - 17.18) | Buy |
| Bollinger Bands (100): | (16.3 - 17.1) | Buy |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 66.51 | Buy |
| Chaikin Money Flow: | -585562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (78.57 - 83.53) | Buy |
| Bollinger Bands (100): | (66.1 - 78.82) | Buy |
CSQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.19 | Buy |
| 20-day SMA: | 16.9 | Buy |
| 50-day SMA: | 16.75 | Buy |
| 200-day SMA: | 16.14 | Buy |
| 8-day EMA: | 17.17 | Buy |
| 20-day EMA: | 17 | Buy |
| 50-day EMA: | 16.84 | Buy |
| 200-day EMA: | 16.15 | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.55 | Buy |
| 20-day SMA: | 81.87 | Buy |
| 50-day SMA: | 77.92 | Buy |
| 200-day SMA: | 73.7 | Buy |
| 8-day EMA: | 83.18 | Buy |
| 20-day EMA: | 81.75 | Buy |
| 50-day EMA: | 78.26 | Buy |
| 200-day EMA: | 74.42 | Buy |
Calamos Strategic Total Return Fund Earnings Growth & CSQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.21 per share, a decrease this year of $2.96 per share, and an increase next year of $3.34 per share.
Calamos Strategic Total Return Fund Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||